Basic Materials / Specialty ChemicalsJakarta
$336.00
-12.00 (-3.45%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 22% · confianza 25%
FCF escenarios
weak_data · normalized FCF $1.3T · quality 82.7/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
51/100
C
Piotroski
5/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$19.87T
P/E
11.1x
↓EV/EBITDA
7.7x
↓ROE
18.3%
↑Gross Margin
44.0%
↑Debt/Equity
0.01
↓TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
+6.7%
FCF CAGR
+0.7%
FCF margin
15.2%
FCF / Net income
0.71x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $8.12T · net income $1.75T · FCF $1.24T
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $8123.69B | $8123.69B | $7471.36B | $7016.88B | $6694.17B |
| Net Income | $1747.46B | $1747.46B | $1664.34B | $1642.17B | $1400.56B |
| EBITDA | $2411.49B | $2411.49B | $2286.57B | $2182.13B | $1927.73B |
| EPS | 29.11 | 29.11 | 27.16 | 26.51 | 22.61 |
| Gross Margin | 44.0% | 44.0% | 44.7% | 45.4% | 40.6% |
| Operating Margin | 23.7% | 23.7% | 23.7% | 24.5% | 22.1% |
| Net Margin | 21.5% | 21.5% | 22.3% | 23.4% | 20.9% |
| Balance Sheet | |||||
| Debt/Equity | 0.01 | 0.01 | 0.01 | 0.00 | 0.01 |
| Current Ratio | 5.15 | 5.15 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $1235.62B | $1235.62B | $1277.45B | $1316.40B | $1210.62B |
| Returns | |||||
| ROE | 18.3% | 18.3% | 17.3% | 16.6% | 14.6% |
| Valuation | |||||
| P/E | 11.11 | 11.11 | 15.32 | 18.71 | 27.64 |
| EV/EBITDA | 7.71 | 7.71 | 10.17 | 13.53 | 19.00 |
| P/B | 2.11 | 2.11 | 2.65 | 3.10 | 4.05 |
| Growth & Yield | |||||
| Revenue Growth | 8.7% | 8.7% | 6.5% | 4.8% | — |
| EPS Growth | 7.2% | 7.2% | 2.5% | 17.2% | — |
| Dividend Yield | 6.6% | 6.6% | — | — | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
3Y implied EPS CAGR
0.8%
EPS terminal req.
$29.81
Spread vs growth
6.4%
5Y implied EPS CAGR
4.4%
EPS terminal req.
$36.08
Spread vs growth
2.8%
10Y implied EPS CAGR
7.2%
EPS terminal req.
$58.10
Spread vs growth
0.0%
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
-19.7%
Start / end P/E
16.8x → 11.5x
EPS bridge
27.16 → 29.11
Residual
-2.2%
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.